Cannassure Therapeutics (Israel) Today
| CSURE Stock | 700.00 17.80 2.48% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Cannassure Therapeutics is selling for under 700.00 as of the 23rd of March 2025; that is 2.48 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 700.0. Cannassure Therapeutics has about a 38 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 23rd of December 2024 and ending today, the 23rd of March 2025. Click here to learn more.
Moving against Cannassure Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Cannassure Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cannassure Therapeutics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cannassure Therapeutics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Founder Chairman | CPA CPA |
| Business Concentration | Healthcare Providers & Services, Healthcare (View all Sectors) |
Cannassure Therapeutics (CSURE) is traded on Tel Aviv Stock Exchange in Israel and employs 44 people. The company currently falls under 'Nano-Cap' category with a current market capitalization of 384.26 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cannassure Therapeutics's market, we take the total number of its shares issued and multiply it by Cannassure Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cannassure Therapeutics operates under Healthcare sector and is part of Healthcare Providers & Services industry. The entity has 51.17 M outstanding shares.
Cannassure Therapeutics generates negative cash flow from operations
Check Cannassure Therapeutics Probability Of Bankruptcy
Ownership AllocationCannassure Therapeutics holds a total of 51.17 Million outstanding shares. Cannassure Therapeutics retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cannassure Ownership Details
Cannassure Therapeutics Risk Profiles
Although Cannassure Therapeutics' alpha and beta are two of the key measurements used to evaluate Cannassure Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.87 | |||
| Standard Deviation | 6.91 | |||
| Variance | 47.7 | |||
| Risk Adjusted Performance | (0.01) |
Cannassure Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cannassure Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Additional Tools for Cannassure Stock Analysis
When running Cannassure Therapeutics' price analysis, check to measure Cannassure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannassure Therapeutics is operating at the current time. Most of Cannassure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cannassure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannassure Therapeutics' price. Additionally, you may evaluate how the addition of Cannassure Therapeutics to your portfolios can decrease your overall portfolio volatility.